MedTrace Logo

Benefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical Patients

NCT06253052 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2025-05-25

No results posted yet for this study

Summary

The purpose of this study is to show if - compared to standard practice - allowing adults undergoing surgical procedures under anaesthesia care to drink clear fluids up to a volume of 200 ml between 2 h prior to the operation and the call to operation room (approximately 30 min prior to anaesthesia induction) will decrease patient thirst and increase patient satisfaction.

Conditions

  • Anesthesia
  • Thirst; Due to Deprivation of Water
  • Aspiration

Interventions

BEHAVIORAL

Additional pre-OP-visit

OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.

BEHAVIORAL

Liberal fasting regime

Patients may drink up to 200 ml clear fluids between 2 h prior to the surgery and the call to operation room.

Sponsors & Collaborators

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Patrick Meybohm, Prof. Dr. · University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

  • Tobias E Haas, Dr. · University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-24
Primary Completion
2024-11-04
Completion
2024-11-04

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06253052 on ClinicalTrials.gov